Skip to main content
. 2016 Sep 21;11(9):e0163382. doi: 10.1371/journal.pone.0163382

Table 3. Incidence and adjusted HR of incident respiratory failure between the non-SLE and SLE cohorts, stratified by comorbidity type.

SLE
No Yes Compared to non-SLE cohort
Variables Event PY Rate Event PY Rate IRR (95% CI) Adjusted HR (95% CI)
Hypertension
No 351 309067 1.14 548 70062 7.82 6.89(6.53–7.26)*** 6.78(5.91–7.78)***
Yes 137 6555 20.9 146 4553 32.1 1.53(1.24–1.90)*** 2.90(2.25–3.74)***
Hyperlipidemia
No 463 313686 1.48 660 73119 9.03 6.12(5.81–6.44)*** 5.76(5.10–6.50)***
Yes 25 1936 12.9 34 1496 22.7 1.76(1.14–2.72)** 5.53(3.04–10.1)***
Diabetes
No 388 311580 1.25 642 73489 8.74 7.02(6.66–7.40)*** 6.55(5.76–7.45)***
Yes 100 4041 24.8 52 1127 46.2 1.87(1.38–2.52)*** 2.34(1.64–3.33)***
COPD
No 452 314718 1.44 670 74231 9.03 6.28(5.97–6.62)*** 6.06(5.37–6.85)***
Yes 36 904 39.8 24 385 62.4 1.57(0.88–2.78) 2.47(1.39–4.41)***
Asthma
No 456 313781 1.45 661 73909 8.94 6.15(5.85–6.48)*** 5.90(5.23–6.67)***
Yes 32 1841 17.4 33 707 46.7 2.69(1.71–4.22)*** 3.46(2.06–5.81)***
Stroke
No 408 313045 1.30 642 73301 8.76 6.72(6.38–7.08)*** 6.38(5.62–7.25)***
Yes 80 2576 31.1 52 1314 39.6 1.27(0.90–1.81) 2.32(1.58–3.40)***
IHD
No 361 308495 1.17 622 71742 8.67 7.41(7.02–7.82)*** 7.08(6.19–8.08)***
Yes 127 7126 17.8 72 2874 25.1 1.41(1.09–1.81)** 2.11(1.57–2.85)***
Pneumonia
No 452 311281 1.45 588 70098 8.39 5.78(5.49–6.08)*** 5.85(5.17–6.63)***
Yes 36 4340 8.29 106 4518 23.5 2.83(2.08–3.85)*** 4.21(2.83–6.27)***
ESRD
No 478 315240 1.52 683 74193 9.21 6.07(5.77–6.39)*** 5.86(5.20–6.61)***
Yes 10 381 26.2 11 423 26.0 0.99(0.46–2.14) 1.96(0.69–5.56)
Pulmonary Embolism
No 480 315360 1.52 678 73949 9.17 6.02(5.72–6.34)*** 5.90(5.24–6.65)***
Yes 8 262 30.5 16 667 24.0 0.79(0.37–1.66) 1.26(0.45–3.52)

SLE, systemic lupus erythematosus; COPD, chronic obstructive pulmonary disease; IHD, ischemic heart disease; ESRD, end-stage renal disease; PY: person-year; Rate: incidence rate (per 1,000 person-y); IRR, incidence rate ratio; HR, hazard ratio; multivariable analysis including age, sex, and comorbidities;

**P < .01,

***P < .001.